BioSpace News Archive

Next Generation Injection Kit Designed by former Takeda Chief Researcher

Julie is co-founder and managing partner of Biomatics Capital Partners.

The Reveal® Q+ for Deoxynivalenol test is designed for the rapid quantification of the mold toxin in grains.

Fund II, raised in less than two and a half months, surpassed its initial target of $125 million and will continue Regal’s strategy of partnering with leading entrepreneurs in the healthcare services space.

The three facilities will implement offerings from the Synapse portfolio to improve workflows, enhance collaborative care and deliver better patient outcomes.

The collaboration will enhance the OrangeTwist professional grade skincare offerings

The Proposed Changes Would Offer Patients with Brain Cancer and Other Rare Diseases Access to Advocacy Oriented “Patient Partner Navigation Services”

Italfarmaco Group announced that Italfarmaco SpA, a member company, has entered into a binding term sheet agreement with Neupharma for an exclusive option to develop and commercialize inhaled teicoplanin.

ODS Medical Inc. is pleased to announce that the company has received Investigational Testing Authorization from Health Canada for its SentryTM System Prototype. With this authorization, ODS Medical will be able to launch a new clinical study in brain cancer surgeries at The Neuro (Montreal Neurological Institute and Hospital).

FUJIFILM Corporation (“Fujifilm”) today announced that it has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark (“Hillerød Manufacturing”) from Biogen.